2024 |
Takeda Pharmaceutical Co - ADR
|
Director and President, Research and Development |
12 M |
-98.8 % |
2023 |
Takeda Pharmaceutical Co - ADR
|
Director and President, Research and Development |
972 M |
8000.0 % |
2022 |
Takeda Pharmaceutical Co - ADR
|
- |
12 M |
0.0 % |
2022 |
Takeda Pharmaceutical Co - ADR
|
Director and President, Research and Development |
12 M |
0.0 % |
2021 |
Takeda Pharmaceutical Co - ADR
|
Director and President, Research and Development |
12 M |
-98.9 % |
2021 |
Takeda Pharmaceutical Co - ADR
|
- |
12 M |
-98.9 % |
2021 |
Takeda Pharmaceutical Co - ADR
|
Director and President, Research and Development |
12 M |
-98.9 % |
2020 |
Takeda Pharmaceutical Co - ADR
|
- |
1.0 B |
- |
2020 |
Takeda Pharmaceutical Co - ADR
|
- |
1.0 B |
- |
2020 |
Takeda Pharmaceutical Co - ADR
|
Director and President, Research and Development |
1.0 B |
- |
2019 |
Takeda Pharmaceutical Co - ADR
|
Director and President, Research and Development |
- |
- |